Investors



EXCHANGE: NASDAQ
Change
Change (%)
Volume
Data as of
Minimum 15 minute delay
Refresh quote

LEARN MORE

INVESTOR KIT

Recent Press Releases

  • AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today that company management is scheduled to present at the JMP Securities 2019 Life Sciences Conference being held June 19-20, 2019 at the St. Regis New York. The presentation is scheduled for Wednesday, June 19, 2019 at 11:30 am ET. An audio replay of the presentation will be availablemore...
  • AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures announced today that it has received FDA approval for its proposed labeling updates for the ORBERA® Intragastric Balloon System. The goal of the labeling updates is to improve patient safety and these will take effect immediately. The updated US Orbera Directions for Use is available heremore...
Business Wire InvestorHQ℠